Results 101 to 110 of about 7,787,676 (175)
Cancer Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background Radiation therapy (RT) is central to curative treatment for oropharyngeal squamous cell carcinoma (OPSCC) but may cause late side effects that can adversely impact quality of life (QOL). As OPSCC treatment becomes more personalised, clinically meaningful QOL endpoints and their predictors are increasingly important.
Anna Lawless +11 more
wiley +1 more source
Diagnostic Cytopathology, Volume 54, Issue 10, Page 724-730, October 2026.ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan +5 more
wiley +1 more source
History of cervical cancer and the role of the human papillomavirus, 1960–2000 [PDF]
, 2009 The history, largely untold, of the development of cervical cytology, of effective screening and its ultimate success in reducing cervical cancer incidence and mortality, and the viral cause of cervical cancer, took place within a complex social ...
core
Health Promotion Journal of Australia, Volume 37, Issue 4, October 2026.ABSTRACT Issue Addressed This study assesses how the concept of (health) research impact has been operationalised in National Health and Medical Research Council (NHMRC) Impact Case Studies, and if and how lived experience research priorities have been considered, to ascertain implications for Australian health and medical research.
Nizam Abdu +6 more
wiley +1 more source
Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review
Health Science Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background and Aims Human papillomavirus (HPV) vaccination is a critical intervention for cervical cancer prevention in Africa; however, program uptake and scale‐up remain limited due to financing constraints. This scoping review mapped existing evidence on HPV vaccine financing in Africa, identifying prevailing funding mechanisms, cost ...
Kafayat Aminu +10 more
wiley +1 more source
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 5, October 2026.HPV vaccination after exposure may confer survival benefits in oropharyngeal cancer patients. Survival advantages appeared regardless of vaccination timing relative to diagnosis, though small sample sizes preclude definitive conclusions. ABSTRACT Objective Childhood HPV vaccination reduces oropharyngeal cancer (OPC) incidence, but evidence regarding ...
Mary Elizabeth Kim +5 more
wiley +1 more source
The human papillomavirus (HPV) vaccine is effective in cervical cancer prevention. However, many barriers to uptake exist and strategies to overcome them are needed.
Mary Kawonga +4 more
core +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2041-2047, October 2026.In women living with HIV, HPV clearance occurred after a mean of approximately 2 years under antiretroviral therapy. Baseline positivity for the high‐risk HPV pool was associated with delayed clearance, suggesting that HPV genotype may influence viral persistence more than immunovirological status in clinically stable patients.
Annunziata Carlea +10 more
wiley +1 more source
Review of Human Papillomavirus Vaccination Programs in United States Schools
Background: School vaccination programs (school-based and school-located) that include the human papillomavirus (HPV) vaccine have been implemented throughout the United States since 2009. Methods: We conducted a review of school HPV vaccination programs
Misra, Sanghamitra M +9 more
core +1 more source
A study of Human Papillomavirus (HPV) types in young South African women and HPV variants in South African couples [PDF]
, 2013 Includes abstract.
Mndende, Xolani-Kakuhle
core +1 more source